MCK McKesson Corporation

Stock NYSE Healthcare

US$887.77 -1.27% Latest close

McKesson Corporation (MCK) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on NYSE. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. If this ticker has no settled sample yet, treat the numbers as a geometric read, not a track record. Information only, not financial advice.

Mid-channel

Price is between the two trend lines. Nothing to act on yet.

Read from the last 2 years of history we hold: rising, drifting +32% a year. The target of US$924.38 is below the nearest ceiling (US$1,184), so it does not depend on a breakout. What would overturn this: a close below US$779.64 β€” the floor of the channel being read β€” after which the trend, not the entry, is what was wrong.

2 years read from
US$779.64 – US$1,184 Rising channel, +32% a year
Position in that channel
27% 0% at the floor, 100% at the ceiling

What broke this trend

The fall
-27% from US$994.043 Mar 2026 β†’ 11 May 2026
Whose problem it was
This companyno peer group to compare against
Does it resolve?
Temporary falls like it have resolved on the record
Regained so far
69%of what it lost
What the record says
87% of 1099 comparable falls came back, typically in 67 days measured across every stock we hold history for, its peer group being too small

The trend broke in March 2026: price fell 27% from 994.04 to 723.50 by May 2026, and has regained 69% of that fall since. Its peers did not fall with it, so this was about the company rather than its sector. The wire that week: β€œIf You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today”. Falls like it have resolved: falls of about 27% here have come back to the old high 87% of the time (1099 comparable falls), typically in 67 days. On that record the fall is treated as temporary, and the trend lines are fitted to the regime it created rather than through it. Priced from that: 1004.77 within 63 days, reached 87% of the time in 1099 comparable falls β€” about 0.16% a day held.

Reported at the time: If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today β€” 26 Feb 2026

Price history, with the path projected 3 months forward

US$400.0US$600.0US$800.0US$1,000US$1,200Oct 23Mar 24Aug 24Jan 25June 25Nov 25Apr 26Sept 26 today BuyTarget Our buy US$840.3 Β· est. 8 Oct 26Our target US$924.4 Β· est. 1 Nov 26
  • Daily close
  • Upper trend line (2 years)
  • Lower trend line (2 years)
  • Dashed after today: projected 3 months
  • Our buy
  • Our target

Suggested path

Buy at or below

US$840.35

level as at 8 Oct 2026

Our target

US$924.38

by 1 Nov 2026

Projected move

10.0%

gross, before costs

Price sits between our buy level and our target.

The lines are drawn where this stock has actually turned: 5 touches on the ceiling, 6 on the floor, each fitted to the slope that catches the most of them. Buying one average daily range below its 50-day mean, on heavier volume than usual and while it is still above its 200-day mean, has come up 791 times; measured against the 6% floor β€” the least a call has to be worth to be worth making, not what it aims at β€” 73% cleared it, typically in 34 days, with price going about 5% against the entry along the way (63% in the worst case we have on record). Trades that have not reached the target within 3 months are counted as misses, whatever they are worth at the time. The prices above are this stock’s own β€” its average, its volatility β€” but the setup is the same one we apply everywhere: derived on eight unrelated tickers, then confirmed on 87 others it was never fitted to. We deliberately do not tune it to each stock: doing so scores worse on history the tuning never saw β€” 58% against 71% β€” because it fits the past rather than the future. On this stock the setup has come up 7 times so far, reaching target 57% of the time β€” too few to mean much on its own. The sell price comes from where this stock is projected to be, not from a minimum worth taking: the fitted path reaches more than 30% above the entry within 90 days, and of the sizes that path supports, 10% is the one that has returned the most per day of money tied up here β€” measured over the 9 times this entry has come up on this chart, reached 78% of the time, typically in 24 days. Smaller sizes got there sooner but paid less for the weeks they used; larger ones need a break above the projected ceiling, which is not the base case. The date published is whichever is later: that typical time, or the day the projected path itself reaches the price. It is a prediction, so it can be revised: if the run tops out before it gets there, the target is cut to what is actually on the table and you are told the same day. An ordinary pullback is not treated as topping out β€” those go on to make a new high about 8 times in 10, so they are ridden through. What triggers the revision is price closing below its 50-day trend and staying there, after which the odds of recovery fall to roughly 3 in 10.

Upper line touches
5
Lower line touches
6
Fit confidence
48%
Fitted
14 Sept 2026

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Sector
Healthcare
Industry
Medical - Distribution
CEO
Brian S. Tyler
Employees
42,300
Country
US

https://www.mckesson.com

Scorecard

Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings β€” that data is licensed and we do not redistribute it.

Valuation
β€”
Profitability
β€”
Financial health
β€”
Cash generation
β€”

Key statistics

Market cap
US$103.21B
Enterprise value
β€”
Beta
0.31
Avg volume
1.12M
Revenue per share
β€”
Dividend yield
β€”
52-week range
687.68-999
Exchange
NYSE

Key ratios

P/E (TTM)
β€”
PEG
β€”
Price / sales
β€”
Price / book
β€”
EV / EBITDA
β€”
Gross margin
β€”
Operating margin
β€”
Net margin
β€”
Current ratio
β€”
Quick ratio
β€”
Debt / equity
β€”
Interest cover
β€”

Income statement

Balance sheet

Cash flow

Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.